# Becton, Dickinson (BDX) — Earnings

BDX · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bdx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $3.23 |
| EPS estimate | $3.14 |
| EPS surprise | +2.82% |
| Revenue surprise | +1.96% |
| Revenue | $5.0B |
| Revenue estimate | $4.9B |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/10795/000001079526000035/bdx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/74f365d9-edb9-0dcb-88e0-25da78ec75e4.html) |

Becton, Dickinson reported fiscal Q3 2026 results on August 6, 2026. Earnings per share came in at $3.23, ahead of the $3.14 estimate by 2.82%. Revenue was $5.0 billion, above the $4.9 billion consensus. Compared with Q3 2025, though, EPS fell about 12% from $3.68 and revenue fell about 9% from $5.5 billion. Sequentially, EPS rose from $2.90 in Q2.

The longer record shows steady gains through fiscal 2025, then a lower base. Annual EPS went from $12.14 in fiscal 2022 to $12.22 in 2023, $13.16 in 2024 and $14.42 in 2025. The first three quarters of fiscal 2026 add up to $8.42, about 20% less than the same period a year earlier. Q1 2026 was the low point in the table at $2.29 per share and $4.5 billion in revenue, and it was also the largest miss, at 18.69% below the estimate. Q4 2025 set the highs here at $3.96 and $5.9 billion. Over the last 20 quarters, Becton, Dickinson topped the EPS estimate 18 times.

The company reported fiscal Q4 between November 4 and November 10 in each of the past five years. That points to early November 2026 for the next report, which will complete fiscal 2026.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2026 | Aug 6, 2026 | $3.14 | $3.23 | 2.82% | $4.9B | $5.0B |
| Q2 2026 | May 7, 2026 | $2.78 | $2.90 | 4.38% | $4.7B | $4.7B |
| Q1 2026 | Feb 9, 2026 | $2.81 | $2.29 | -18.69% | $5.1B | $4.5B |
| Q4 2025 | Nov 6, 2025 | $3.92 | $3.96 | 1.05% | $5.9B | $5.9B |
| Q3 2025 | Aug 7, 2025 | $3.40 | $3.68 | 8.20% | $5.5B | $5.5B |
| Q2 2025 | May 1, 2025 | $3.28 | $3.35 | 2.12% | $5.4B | $5.3B |
| Q1 2025 | Feb 5, 2025 | $2.98 | $3.43 | 15.18% | $5.1B | $5.2B |
| Q4 2024 | Nov 7, 2024 | $3.77 | $3.81 | 1.12% | $5.4B | $5.4B |
| Q3 2024 | Aug 1, 2024 | $3.31 | $3.50 | 5.79% | $5.1B | $5.1B |
| Q2 2024 | May 2, 2024 | $2.97 | $3.17 | 6.77% | $5.0B | $5.0B |
| Q1 2024 | Feb 1, 2024 | $2.40 | $2.68 | 11.66% | $4.7B | $4.7B |
| Q4 2023 | Nov 9, 2023 | $3.43 | $3.42 | -0.15% | $5.0B | $5.1B |
| Q3 2023 | Aug 3, 2023 | $2.91 | $2.96 | 1.60% | $4.8B | $4.9B |
| Q2 2023 | May 4, 2023 | $2.74 | $2.86 | 4.25% | $4.7B | $4.8B |
| Q1 2023 | Feb 2, 2023 | $2.68 | $2.98 | 11.38% | $4.5B | $4.6B |
| Q4 2022 | Nov 10, 2022 | $2.74 | $2.75 | 0.27% | $4.7B | $4.8B |
| Q3 2022 | Aug 4, 2022 | $2.50 | $2.66 | 6.48% | $4.5B | $4.6B |
| Q2 2022 | May 5, 2022 | $2.93 | $3.18 | 8.58% | $4.8B | $5.0B |
| Q1 2022 | Feb 3, 2022 | $2.78 | $3.55 | 27.61% | $4.8B | $5.0B |
| Q4 2021 | Nov 4, 2021 | $2.39 | $2.53 | 5.53% | $4.9B | $5.1B |

## Frequently Asked Questions

### When did Becton, Dickinson (BDX) last report earnings?

Becton, Dickinson last reported on Aug 6, 2026, covering fiscal Q3 2026.

### Did BDX beat earnings estimates?

Yes. Becton, Dickinson reported EPS of $3.23 for Q3 2026 against a $3.14 estimate — a 2.82% beat.

### How much revenue did BDX report last quarter?

Becton, Dickinson reported $5.0B in revenue for Q3 2026, against a consensus estimate of $4.9B.

## Similar Stocks

- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [COO](https://www.lighthorse.io/tickers/coo) — The Cooper Companies, Inc.  - Common Stock
- [DVA](https://www.lighthorse.io/tickers/dva) — DaVita Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).